The store will not work correctly when cookies are disabled.
3-ethoxycarbonyl-4-(4-methoxyphenyl)-4H-pyridine-1-carboxylic acid phenyl ester
ID: ALA229130
PubChem CID: 23661654
Max Phase: Preclinical
Molecular Formula: C22H21NO5
Molecular Weight: 379.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)C1=CN(C(=O)Oc2ccccc2)C=CC1c1ccc(OC)cc1
Standard InChI: InChI=1S/C22H21NO5/c1-3-27-21(24)20-15-23(22(25)28-18-7-5-4-6-8-18)14-13-19(20)16-9-11-17(26-2)12-10-16/h4-15,19H,3H2,1-2H3
Standard InChI Key: VGWUGLWTKLFQCP-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
12.7736 -6.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7724 -6.9232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4872 -7.3360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2037 -6.9227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2008 -6.0922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4854 -5.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4870 -8.1610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7695 -8.5734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7673 -9.3948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4799 -9.8113 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1963 -9.4002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2001 -8.5726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4765 -10.6363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7604 -11.0459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1893 -11.0517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0476 -10.6305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0555 -9.8059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3435 -9.3906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6264 -9.8003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6257 -10.6295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3383 -11.0411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9155 -8.1617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6291 -8.5758 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9174 -7.3367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4830 -4.8580 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7673 -4.4477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3444 -8.1649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0580 -8.5790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
13 14 1 0
7 3 1 0
13 15 2 0
7 8 1 0
14 16 1 0
3 4 2 0
16 17 2 0
17 18 1 0
4 5 1 0
18 19 2 0
2 3 1 0
19 20 1 0
5 6 2 0
20 21 2 0
21 16 1 0
7 12 1 0
12 22 1 0
8 9 2 0
22 23 1 0
9 10 1 0
22 24 2 0
10 11 1 0
6 25 1 0
11 12 2 0
25 26 1 0
6 1 1 0
23 27 1 0
10 13 1 0
27 28 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.41 | Molecular Weight (Monoisotopic): 379.1420 | AlogP: 4.25 | #Rotatable Bonds: 5 |
Polar Surface Area: 65.07 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.00 | CX LogD: 4.00 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.73 | Np Likeness Score: -0.09 |
References
1. Voigt B, Coburger C, Monár J, Hilgeroth A.. (2007) Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors., 15 (15): [PMID:17533131] [10.1016/j.bmc.2007.05.036] |